NCT04418999View on ClinicalTrials.gov

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
KeratoconusDry EyeAllergy
Interventions
DRUG

dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use

Experimental

DRUG

Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly

Active Comparator

Trial Locations (1)

60616

Illinois Eye Institute, Chicago

All Listed Sponsors
lead

Illinois College of Optometry

OTHER

NCT04418999 - Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus | Biotech Hunter | Biotech Hunter